Global Immunoprotein Diagnostic Testing Market 2017-2021

Detailed TOC of Global Immunoprotein Diagnostic Testing Market 2017-2021

Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
• Market outline
PART 05: Market landscape
• Overview
• Market size and forecast
• Five forces analysis
PART 06: Segmentation by application
• Overview
• Infectious disease testing
• Oncology and endocrinology testing
• Autoimmune testing
• Allergy testing
PART 07: Segmentation by end-user
• Overview
• Hospital and clinics
• Diagnostic laboratories
PART 08: Segmentation by geography
• Overview
• Americas
• EMEA
• APAC
PART 09: Decision framework
PART 10: Drivers and challenges
• Market drivers
• Market challenges
PART 11: Market trends
• Growing focus on next-generation products
• Increasing use of cloud-based solutions
• Emergence of nanoparticle-based immunoassay for protein test
PART 12: Vendor landscape
• Competitive landscape
PART 13: Key vendor analysis
• Beckman Coulter
• DiaSorin
• F. Hoffmann-La Roche
• Siemens Healthineers
• Key companies to watch
• Other prominent vendors
PART 14: Appendix
• List of abbreviations
List of Exhibits
Exhibit 01: Share of global immunoprotein diagnostic testing market in global immunoassay market 2016
Exhibit 02: Global immunoprotein diagnostic testing market: Overview 2016-2021
Exhibit 03: Global immunoprotein diagnostic testing market 2016-2021 ($ billions)
Exhibit 04: Five forces analysis
Exhibit 05: Global immunoprotein diagnostic testing market: Overview of segmentation by application
Exhibit 06: Global infectious disease testing market 2016-2021 ($ billions)
Exhibit 07: Global oncology and endocrinology testing market 2016-2021 ($ billions)
Exhibit 08: Global autoimmune testing market 2016-2021 ($ billions)
Exhibit 09: Global allergy testing market 2016-2021 ($ billions)
Exhibit 10: Global immunoprotein diagnostic testing market: Overview of segmentation by end-users
Exhibit 11: Global immunoprotein diagnostic testing market: Buying criteria of end-users
Exhibit 12: Global immunoprotein diagnostic testing market: Overview of segmentation by geography
Exhibit 13: Immunoprotein diagnostic testing market in Americas: Overview
Exhibit 14: Immunoprotein diagnostic testing market in Americas 2016-2021 ($ billions)
Exhibit 15: Immunoprotein diagnostic testing market in EMEA: Overview
Exhibit 16: Immunoprotein diagnostic testing market in EMEA 2016-2021 ($ billions
Exhibit 17: Immunoprotein diagnostic testing market in APAC: Overview
Exhibit 18: Immunoprotein diagnostic testing market in APAC 2016-2021 ($ billions)
Exhibit 19: Prevalence of infectious diseases
Exhibit 20: Companies offering chromatographic tests
Exhibit 21: Automation products offered by vendors
Exhibit 22: Cost of immunoprotein diagnostic testing products developed by Beckman Coulter
Exhibit 23: Global immunoprotein diagnostic testing market: Competitive structure analysis 2016
Exhibit 24: Global immunoprotein diagnostic testing market: Participants 2016
Exhibit 25: Global immunoprotein diagnostic testing market: Strategic success factors of companies 2016
Exhibit 26: Beckman Coulter: Key highlights
Exhibit 27: Beckman Coulter: Strength assessment
Exhibit 28: Beckman Coulter: Strategy assessment
Exhibit 29: Beckman Coulter: Opportunity assessment
Exhibit 30: DiaSorin: Key highlights
Exhibit 31: DiaSorin: Strength assessment
Exhibit 32: DiaSorin: Strategy assessment
Exhibit 33: DiaSorin: Opportunity assessment
Exhibit 34: F. Hoffmann-La Roche: Key highlights
Exhibit 35: F. Hoffmann-La Roche: Strength assessment
Exhibit 36: F. Hoffmann-La Roche: Strategy assessment
Exhibit 37: F. Hoffmann-La Roche: Opportunity assessment
Exhibit 38: Siemens Healthineers: Key highlights
Exhibit 39: Siemens Healthineers: Strength assessment
Exhibit 40: Siemens Healthineers: Strategy assessment
Exhibit 41: Siemens Healthineers: Opportunity assessment
Exhibit 42: Abbott: Overview
Exhibit 43: Alere: Overview